FindTrial
Sign In

Efficacy of Sufoof e Amla and Sharbat e Bazoori Moatadil in Urinary Tract Infection

Efficacy of Sufoof-e-Amla and Sharbat-e-Bazoori Mo’atadil in Urinary Tract Infection- A Randomized Controlled Clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065867
Enrollment
60
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Sufoof-e-Amla and Sharbat-e-Bazoori Moatadil: Sufoof-e-Amla 4g and Sharbat-e-Bazoori moatadil 20ml will be given orally twice a day for 14 days Control Intervention1: Tablet Ofloxacin(4

Sponsors

Department of Moalejat Ajmal Khan Tibbiya College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of UTI with the help of subjective and objective parameters. Patients of either gender. Patients in the age group of 20 to 60 years. Patients who give written consent. Non diabetic Subjective criteria It includes: 1. Dysuria 2. Frequency of micturition 3. Fever with or without chills 4. Suprapubic pain Objective criteria 1. Urine: routine and microscopic. 2. CBC with ESR

Exclusion criteria

Exclusion criteria: Patients below 20 years of age. Patients above 60 years of age. Pregnant & lactating mothers. Patients with diabetes mellitus. Patient suffering from any congenital abnormality of urinary tract. Patients suffering from renal failure or CKD. Patients of obstructive uropathy. Patients who have been taken prior antibiotics within 2 weeks for the same. Mentally retarded patients. Patients with evidence of severe UTI. Patients who fail to give consent. Patients who fail to follow up

Design outcomes

Primary

MeasureTime frame
Improvement in objective parameters Objective parameters 1. Urine: routine and microscopic. 2. CBC with ESRTimepoint: 3 weeks with weekly follow up—

Secondary

MeasureTime frame
Improvement in subjective parameters Subjective parameters 1. Dysuria 2. Frequency of micturition 3. Fever with or without chills 4. Suprapubic painTimepoint: 3 weeks with follow up weekly—

Countries

India

Contacts

Public ContactHumaira Bano

Ajmal khan tibbya college Aligarh Muslim University Aligarh

drbdkhanamu@gmail.com9412333174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026